Relationships of Fat Mass Index and Fat-Free Mass Index with Low-Density Lipoprotein Cholesterol Levels in the Tohoku Medical Megabank Community-Based Cohort Study-Reference-Cited by-同舟云学术

Relationships of Fat Mass Index and Fat-Free Mass Index with Low-Density Lipoprotein Cholesterol Levels in the Tohoku Medical Megabank Community-Based Cohort Study

Published:2024-06-01 Issue:6 Volume:31 Page:979-1003
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Takase Masato¹,Nakamura Tomohiro²³,Nakaya Naoki¹²,Kogure Mana¹²,Hatanaka Rieko¹²,Nakaya Kumi¹²,Chiba Ippei¹²,Kanno Ikumi¹²,Nochioka Kotaro¹²⁴,Tsuchiya Naho¹²,Hirata Takumi²⁵,Obara Taku¹²,Ishikuro Mami¹²,Uruno Akira²,Kobayashi Tomoko¹²⁴,Kodama Eiichi N²⁶,Hamanaka Yohei²,Orui Masatsugu¹²,Ogishima Soichi¹²,Nagaie Satoshi¹²,Fuse Nobuo¹²,Sugawara Junichi¹²⁴⁷,Izumi Yoko¹²,Kuriyama Shinichi¹²⁶,Hozawa Atsushi¹²,

Affiliation:

1. Graduate School of Medicine, Tohoku University

2. Tohoku Medical Megabank Organization, Tohoku University

3. Kyoto Women's University

4. Tohoku University Hospital, Tohoku University

5. Institute for Clinical and Translational Science, Nara Medical University

6. International Research Institute of Disaster Science, Tohoku University

7. Suzuki Memorial Hospital

Publisher

Japan Atherosclerosis Society

Link

https://www.jstage.jst.go.jp/article/jat/31/6/31_64535/_pdf

Reference46 articles.

1. 1) Kopin L, Lowenstein C. Dyslipidemia. Ann Intern Med, 2017; 167: ITC81-ITC96

2. 2) Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Diagnostic criteria for dyslipidemia. J Atheroscler Thromb, 2013; 20: 655-660

3. 3) Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S; Committee for Epidemiology and Clinical Management of Atherosclerosis. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb, 2018; 25: 846-984

4. 4) Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2019; 140: e596-e646

5. 5) Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J, 2020; 41: 111-188